MedTrace Logo

XP1000 RF Therapy on Waist Circumference Reduction

NCT02271672 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-06-18

No results posted yet for this study

Summary

This study was designed to demonstrate safety and efficacy of the XP1000 RF for non-invasive temporary reduction of waist circumference by disruption of adipocyte cells.

Conditions

  • Circumferential Reduction
  • Waist Circumferential Reduction

Interventions

DEVICE

XP1000 RF

Treatment of adipose tissue within the fat layer with XP1000 RF.

DEVICE

sham XP1000 RF

Treatment of adipose tissue within the fat layer with XP1000 RF.

Sponsors & Collaborators

  • BTL Industries Ltd.

    lead INDUSTRY

Principal Investigators

  • Radina Denkova, MD · Aesthe Beauty Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-03-31
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271672 on ClinicalTrials.gov